Compare KMI Wire Cable Tbk (KBLI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KMI Wire Cable Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? KMI Wire Cable Tbk trades at Rp340 (market cap 1.34T, 650.3K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: KMI Wire Cable Tbk is far larger — about 12.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KBLI | SCPI | |
|---|---|---|
Market Cap | 1.34T | 104.4B |
Volume | 650.3K | — |
Lot | 6.5K | — |
Turnover | 218.33M | — |
Average Price | 335.73 | — |
Value | 218.33M | — |
Indicative Equilibrium Price | 340 | — |
Indicative Equilibrium Volume | 136 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KMI Wire Cable Tbk
PT KMI Wire and Cable Tbk (the Company) formerly PT. GT Kabel Indonesia is one of the largest telecommunications and power cable producer. It is owned 53% by Gadjah Tunggal Group. It was established in 1972 by Electro GmbH of Germany (today known as Alcatel Kabelmetal) and PT Gunung Ngadeg Djaya.The Company was established wtihin the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970, based on deed No. 42 dated January 19, 1972 of Djojo Muljadi, SH, notary in Jakarta
Read more on KBLI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
